Israel
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 22.92 M
|
Dec. 31, 2023 | USD 19.58 | -1.51% |
|
Israel |
|
2 |
USD 22.68 M
|
Dec. 31, 2023 | USD 6.90 | -0.18% |
|
Israel |
|
3 |
USD 15.06 M
|
Dec. 31, 2023 | USD 0.01 | -0.18% |
|
Israel |
|
4 |
USD 9.98 M
|
Dec. 31, 2023 | USD 2.86 | -4.35% |
|
Israel |
|
5 |
USD 9.14 M
|
Dec. 31, 2023 | USD 0.01 | -0.18% |
|
Israel |
|
6 |
USD 8.84 M
|
June 30, 2024 | USD 4.42 | -0.18% |
|
Israel |
|
7 |
USD 6.04 M
|
Dec. 31, 2023 | USD 2.19 | -6.01% |
|
Israel |
|
8 |
USD 5.45 M
|
Dec. 31, 2023 | USD 0.02 | -0.18% |
|
Israel |
|
9 |
USD 5.30 M
|
Dec. 31, 2023 | USD 3.70 | -2.63% |
|
Israel |
|
10 |
USD 4.62 M
|
Dec. 31, 2023 | USD 3.12 | -5.74% |
|
Israel |
|
11 |
USD 3.90 M
|
Dec. 31, 2023 | USD 1.11 | 4.72% |
|
Israel |
|
12 |
USD 3.50 M
|
Dec. 31, 2023 | USD 2.04 | NA |
|
Israel |
|
13 |
USD 3.08 M
|
Dec. 31, 2023 | USD 2.33 | -0.18% |
|
Israel |
|
14 |
USD 2.38 M
|
Dec. 31, 2023 | USD 0.11 | -0.18% |
|
Israel |
|
15 |
USD 896.46 K
|
Dec. 31, 2023 | USD 1.88 | -0.18% |
|
Israel |
|
16 |
USD 360.00 K
|
Dec. 31, 2023 | USD 1.10 | -0.18% |
|
Israel |
|
17 |
USD -738.93 K
|
Dec. 31, 2023 | USD 0.08 | -1.82% |
|
Israel |
The Clinical Trials company in Israel with the highest Net Cash Used Provided By Financing Activities is MediWound Ltd. (NasdaqGM: MDWD) at USD 22.92 M.
The Clinical Trials company in Israel with the lowest Net Cash Used Provided By Financing Activities is Bio-View Ltd (Tel Aviv Stock Exchange: BIOV.TA) at USD -738.93 K.
The top 10 Clinical Trials companies in Israel by Net Cash Used Provided By Financing Activities are MediWound Ltd., Kamada Ltd., BioLineRx Ltd., PolyPid Ltd., Can-Fite BioPharma Ltd., Pluri Inc., Entera Bio Ltd., Purple Biotech Ltd., Alpha Tau Medical Ltd. and PainReform Ltd..
The bottom 10 Clinical Trials companies in Israel by Net Cash Used Provided By Financing Activities are Bio-View Ltd, Enlivex Therapeutics Ltd., BioLight Life Sciences Ltd., Tikun Olam-Cannbit Pharmaceuticals Ltd, Compugen Ltd., Chemomab Therapeutics Ltd., NeuroSense Therapeutics Ltd., PainReform Ltd., Alpha Tau Medical Ltd. and Purple Biotech Ltd..